Ko Rii

Title: Ko Rii: Innovator in Immune Tolerance and Nucleic Acid Research

Introduction

Ko Rii is a prominent inventor based in Chofu, Japan. He has made significant contributions to the field of immunology and drug development, holding a total of 2 patents. His work focuses on innovative methods to induce immune tolerance, which is crucial in transplantation therapy.

Latest Patents

Ko Rii's latest patents include an "Immune Tolerance Inducer" and a "Nucleic Acid/Polysaccharide Complex." The immune tolerance inducer aims to provide a drug and method for effectively inducing donor-specific immune tolerance in recipients undergoing transplantation therapy. This involves delivering a complex of siRNA for a costimulatory factor and schizophyllan to Dectin-1 expressing cells, which helps regulate their function and induce immunosuppression. The nucleic acid/polysaccharide complex patent describes a highly stable complex formed by combining siRNA and schizophyllan with polydeoxyadenine, enhancing the stability and efficacy of the treatment.

Career Highlights

Ko Rii is currently associated with Napajen Pharma, Inc., where he continues to advance his research and development efforts. His innovative approaches have the potential to transform therapeutic strategies in immunology.

Collaborations

Throughout his career, Ko Rii has collaborated with notable colleagues, including Kazuo Sakurai and Masakazu Kobayashi. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Napajen Pharma, Inc.

Conclusion

Ko Rii's contributions to the field of immunology through his patents and research at Napajen Pharma, Inc. highlight his role as a key innovator in developing therapies for immune tolerance. His work is paving the way for advancements in transplantation therapy and beyond.